Form 483

Teva Parenteral Medicines Inc Form 483, 2010-05-14

FDA issued a Form 483 to Teva Parenteral Medicines Inc on 2010-05-14 with 23 public-safe observations.

483· Form 483 issued23 observations

Teva Parenteral Medicines Inc · Irvine, United States · Issued May 14, 2010

Overview

  • 23 public-safe observations are available for this inspection.
  • 22 structured CFR citations are represented.
  • 6 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

14 May 2010
21 CFR 211.22(c)

Approve or reject procedures or specs

Cited by Joey V Quitania, Jennifer M Gogley, Comyar Shoghi, Carla J Lundi, Virgilio F Pacio, Kim L Thomas Cruse

14 May 2010
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Joey V Quitania, Jennifer M Gogley, Comyar Shoghi, Carla J Lundi, Virgilio F Pacio, Kim L Thomas Cruse

14 May 2010
21 CFR 211.25(a)

Training--operations, GMPs, written procedures

Cited by Joey V Quitania, Jennifer M Gogley, Comyar Shoghi, Carla J Lundi, Virgilio F Pacio, Kim L Thomas Cruse

14 May 2010
21 CFR 211.25(c)

Inadequate number of personnel

Cited by Joey V Quitania, Jennifer M Gogley, Comyar Shoghi, Carla J Lundi, Virgilio F Pacio, Kim L Thomas Cruse

14 May 2010
21 CFR 211.63

Equipment Design, Size and Location

Cited by Joey V Quitania, Jennifer M Gogley, Comyar Shoghi, Carla J Lundi, Virgilio F Pacio, Kim L Thomas Cruse

Inspected site

TPTeva Parenteral Medicines IncIrvine, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.192Cited across public-safe Form 483 observations2x
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.100(b)Cited across public-safe Form 483 observations1x
21 CFR 211.110(a)Cited across public-safe Form 483 observations1x
21 CFR 211.111Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)(4)Cited across public-safe Form 483 observations1x
21 CFR 211.165(d)Cited across public-safe Form 483 observations1x
21 CFR 211.165(e)Cited across public-safe Form 483 observations1x
21 CFR 211.182Cited across public-safe Form 483 observations1x
21 CFR 211.22(c)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x
21 CFR 211.25(c)Cited across public-safe Form 483 observations1x
21 CFR 211.63Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x
21 CFR 211.68(a)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(2)Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(3)Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(6)Cited across public-safe Form 483 observations1x
21 CFR 314.81(b)(1)(ii)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 23 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere